SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-024817
Filing Date
2023-05-30
Accepted
2023-05-30 16:03:36
Documents
12
Period of Report
2023-05-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rani-20230525.htm   iXBRL 8-K 92150
  Complete submission text file 0000950170-23-024817.txt   214596

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20230525.xsd EX-101.SCH 2493
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20230525_lab.xml EX-101.LAB 14018
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20230525_pre.xml EX-101.PRE 10303
6 EXTRACTED XBRL INSTANCE DOCUMENT rani-20230525_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 23976273
SIC: 2834 Pharmaceutical Preparations